Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03089645 |
| Title | MEDI5083 Alone and in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MedImmune LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Hackensack | New Jersey | 07601-2191 | United States | Details | |
| Research Site | Providence | Rhode Island | 02903 | United States | Details | |
| Research Site | Nashville | Tennessee | 37203 | United States | Details | |
| Research Site | Salt Lake City | Utah | 84112 | United States | Details | |
| Research Site | Clayton | 3168 | Australia | Details | ||
| Research Site | Melbourne | 3000 | Australia | Details | ||
| Research Site | Melbourne | 3004 | Australia | Details | ||
| Research Site | Randwick | 2031 | Australia | Details |